Recent advances in understanding and managing chordomas

Carlos A. Bagley, Carl Youssef, Salah Aoun, Jessica R. Moreno

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Chordomas are rare primary bone tumors arising from embryonic remnants of the notochord. They are slow-growing, locally aggressive, and destructive and typically involve the axial skeleton. Genetic studies have identified several mutations implicated in the pathogenesis of these tumors. Treatment poses a challenge given their insidious progression, degree of local invasion at presentation, and high recurrence rate. They tend to respond poorly to conventional chemotherapy and radiation. This makes radical resection the mainstay of their treatment. Recent advances in targeted chemotherapy and focused particle beam radiation, however, have improved the management and prognosis of these tumors.

Original languageEnglish (US)
Article number2902
JournalF1000Research
Volume5
DOIs
StatePublished - Jan 1 2016

Fingerprint

Chordoma
Tumors
Chemotherapy
Radiation
Notochord
Drug Therapy
Neoplasms
Particle beams
Skeleton
Bone
Bone and Bones
Recurrence
Mutation
Therapeutics

Keywords

  • Chordoma
  • Chordomas
  • Focused particle beam radiation
  • Primary bone tumors
  • Primary bone tumours
  • Targeted chemotherapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Recent advances in understanding and managing chordomas. / Bagley, Carlos A.; Youssef, Carl; Aoun, Salah; Moreno, Jessica R.

In: F1000Research, Vol. 5, 2902, 01.01.2016.

Research output: Contribution to journalReview article

Bagley, Carlos A. ; Youssef, Carl ; Aoun, Salah ; Moreno, Jessica R. / Recent advances in understanding and managing chordomas. In: F1000Research. 2016 ; Vol. 5.
@article{94689fa9e7404b6c8e8ee5888f07c6c4,
title = "Recent advances in understanding and managing chordomas",
abstract = "Chordomas are rare primary bone tumors arising from embryonic remnants of the notochord. They are slow-growing, locally aggressive, and destructive and typically involve the axial skeleton. Genetic studies have identified several mutations implicated in the pathogenesis of these tumors. Treatment poses a challenge given their insidious progression, degree of local invasion at presentation, and high recurrence rate. They tend to respond poorly to conventional chemotherapy and radiation. This makes radical resection the mainstay of their treatment. Recent advances in targeted chemotherapy and focused particle beam radiation, however, have improved the management and prognosis of these tumors.",
keywords = "Chordoma, Chordomas, Focused particle beam radiation, Primary bone tumors, Primary bone tumours, Targeted chemotherapy",
author = "Bagley, {Carlos A.} and Carl Youssef and Salah Aoun and Moreno, {Jessica R.}",
year = "2016",
month = "1",
day = "1",
doi = "10.12688/f1000research.9499.1",
language = "English (US)",
volume = "5",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Recent advances in understanding and managing chordomas

AU - Bagley, Carlos A.

AU - Youssef, Carl

AU - Aoun, Salah

AU - Moreno, Jessica R.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Chordomas are rare primary bone tumors arising from embryonic remnants of the notochord. They are slow-growing, locally aggressive, and destructive and typically involve the axial skeleton. Genetic studies have identified several mutations implicated in the pathogenesis of these tumors. Treatment poses a challenge given their insidious progression, degree of local invasion at presentation, and high recurrence rate. They tend to respond poorly to conventional chemotherapy and radiation. This makes radical resection the mainstay of their treatment. Recent advances in targeted chemotherapy and focused particle beam radiation, however, have improved the management and prognosis of these tumors.

AB - Chordomas are rare primary bone tumors arising from embryonic remnants of the notochord. They are slow-growing, locally aggressive, and destructive and typically involve the axial skeleton. Genetic studies have identified several mutations implicated in the pathogenesis of these tumors. Treatment poses a challenge given their insidious progression, degree of local invasion at presentation, and high recurrence rate. They tend to respond poorly to conventional chemotherapy and radiation. This makes radical resection the mainstay of their treatment. Recent advances in targeted chemotherapy and focused particle beam radiation, however, have improved the management and prognosis of these tumors.

KW - Chordoma

KW - Chordomas

KW - Focused particle beam radiation

KW - Primary bone tumors

KW - Primary bone tumours

KW - Targeted chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=85010912637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010912637&partnerID=8YFLogxK

U2 - 10.12688/f1000research.9499.1

DO - 10.12688/f1000research.9499.1

M3 - Review article

C2 - 28105324

AN - SCOPUS:85010912637

VL - 5

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 2902

ER -